In vitro effectiveness of four cephalosporins against Shigellae and clinical ineffectiveness of cephaloglycin.
D000284:Administration, Oral; D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use; D002506:Cephalexin / Q000494:pharmacology; D002507:Cephaloglycin / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D002509:Cephaloridine / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D002512:Cephalothin / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D004405:Dysentery, Bacillary / Q000188:drug therapy / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D009355:Neomycin / Q000627:therapeutic use; D010403:Penicillin Resistance; D012760:Shigella / Q000187:drug effects*; D012763:Shigella flexneri / Q000187:drug effects; D012764:Shigella sonnei / Q000187:drug effects
D002511:Cephalosporins; D000667:Ampicillin; D009355:Neomycin; D002509:Cephaloridine; D002507:Cephaloglycin; D002506:Cephalexin; D002512:Cephalothin